Cargando…

{2,2-Bis[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]propane}bis­(N,N-di­methyl­formamide)copper(II) bis­(hexa­fluoridoantimonate)

In the title compound, [Cu(C(17)H(30)N(2)O(2))(C(3)H(7)NO)(2)][SbF(6)](2), which is a potential catalyst in the asymmetric Gosteli–Claisen rearrangement, the Cu atom adopts a distorted cis-CuN(2)O(2) square-planar geometry arising from N,N′-bidentate coordin­ation by the chiral ligand and two O-bond...

Descripción completa

Detalles Bibliográficos
Autores principales: Rehbein, Julia, Schürmann, Markus, Preut, Hans, Hiersemann, Martin
Formato: Texto
Lenguaje:English
Publicado: International Union of Crystallography 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2969361/
https://www.ncbi.nlm.nih.gov/pubmed/21582678
http://dx.doi.org/10.1107/S1600536809020364
_version_ 1782190125979009024
author Rehbein, Julia
Schürmann, Markus
Preut, Hans
Hiersemann, Martin
author_facet Rehbein, Julia
Schürmann, Markus
Preut, Hans
Hiersemann, Martin
author_sort Rehbein, Julia
collection PubMed
description In the title compound, [Cu(C(17)H(30)N(2)O(2))(C(3)H(7)NO)(2)][SbF(6)](2), which is a potential catalyst in the asymmetric Gosteli–Claisen rearrangement, the Cu atom adopts a distorted cis-CuN(2)O(2) square-planar geometry arising from N,N′-bidentate coordin­ation by the chiral ligand and two O-bonded dimethyl­formamide mol­ecules. Two short C—H⋯O contacts occur within the ligand and two weak inter­molecular C—H⋯F bonds may help to establish the packing.
format Text
id pubmed-2969361
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-29693612010-12-30 {2,2-Bis[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]propane}bis­(N,N-di­methyl­formamide)copper(II) bis­(hexa­fluoridoantimonate) Rehbein, Julia Schürmann, Markus Preut, Hans Hiersemann, Martin Acta Crystallogr Sect E Struct Rep Online Metal-Organic Papers In the title compound, [Cu(C(17)H(30)N(2)O(2))(C(3)H(7)NO)(2)][SbF(6)](2), which is a potential catalyst in the asymmetric Gosteli–Claisen rearrangement, the Cu atom adopts a distorted cis-CuN(2)O(2) square-planar geometry arising from N,N′-bidentate coordin­ation by the chiral ligand and two O-bonded dimethyl­formamide mol­ecules. Two short C—H⋯O contacts occur within the ligand and two weak inter­molecular C—H⋯F bonds may help to establish the packing. International Union of Crystallography 2009-06-06 /pmc/articles/PMC2969361/ /pubmed/21582678 http://dx.doi.org/10.1107/S1600536809020364 Text en © Rehbein et al. 2009 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Metal-Organic Papers
Rehbein, Julia
Schürmann, Markus
Preut, Hans
Hiersemann, Martin
{2,2-Bis[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]propane}bis­(N,N-di­methyl­formamide)copper(II) bis­(hexa­fluoridoantimonate)
title {2,2-Bis[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]propane}bis­(N,N-di­methyl­formamide)copper(II) bis­(hexa­fluoridoantimonate)
title_full {2,2-Bis[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]propane}bis­(N,N-di­methyl­formamide)copper(II) bis­(hexa­fluoridoantimonate)
title_fullStr {2,2-Bis[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]propane}bis­(N,N-di­methyl­formamide)copper(II) bis­(hexa­fluoridoantimonate)
title_full_unstemmed {2,2-Bis[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]propane}bis­(N,N-di­methyl­formamide)copper(II) bis­(hexa­fluoridoantimonate)
title_short {2,2-Bis[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]propane}bis­(N,N-di­methyl­formamide)copper(II) bis­(hexa­fluoridoantimonate)
title_sort {2,2-bis[(4s)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]propane}bis­(n,n-di­methyl­formamide)copper(ii) bis­(hexa­fluoridoantimonate)
topic Metal-Organic Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2969361/
https://www.ncbi.nlm.nih.gov/pubmed/21582678
http://dx.doi.org/10.1107/S1600536809020364
work_keys_str_mv AT rehbeinjulia 22bis4s4tertbutyl45dihydro13oxazol2ylpropanebisnndimethylformamidecopperiibishexafluoridoantimonate
AT schurmannmarkus 22bis4s4tertbutyl45dihydro13oxazol2ylpropanebisnndimethylformamidecopperiibishexafluoridoantimonate
AT preuthans 22bis4s4tertbutyl45dihydro13oxazol2ylpropanebisnndimethylformamidecopperiibishexafluoridoantimonate
AT hiersemannmartin 22bis4s4tertbutyl45dihydro13oxazol2ylpropanebisnndimethylformamidecopperiibishexafluoridoantimonate